Zoetis | ZTS - Pre Tax Profit

Stock Price
114.69
Daily Change
-0.28 -0.24%
Monthly
-2.98%
Yearly
-26.32%
Q2 Forecast
114.37

Zoetis reported $887M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Align Technology USD 148.89M 27.71M Mar/2026
Bayer EUR -1.16B 735M Sep/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Dentsply International USD -230M 77M Sep/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Henry Schein USD 137M 16M Sep/2025
Idexx Laboratories USD 306.98M 37.79M Dec/2025
Illumina USD 377M 157M Dec/2025
IQVIA Holdings USD 537M 5.62B Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Laboratory Of America USD 190.6M 146.4M Dec/2025
Merck USD 3.42B 3.32B Dec/2025
Neogen USD 28M 15.81M Sep/2025
Pacira USD 571K 8.95M Dec/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Sanofi EUR -1.16B 5.5B Dec/2025
Sanofi EUR -1.16B 6.23B Dec/2025
Zoetis USD 887M 15M Sep/2025